Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $200

Benzinga · 2d ago
Barclays analyst Emily Field maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $185 to $200.